Share chart Fresh2 Group Limited
Extended chart
Simple chart
About Fresh2 Group Limited
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. more details| IPO date | 2023-05-22 |
|---|---|
| ISIN | US03635R2067 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | cny |
| Сайт | https://fresh2.co |
| Цена ао | 0.85 |
| Change price per day: | 0% (0.85) |
|---|---|
| Change price per week: | 0% (0.85) |
| Change price per month: | 0% (0.85) |
| Change price per 3 month: | 0% (0.85) |
| Change price per half year: | -33.59% (1.28) |
| Change price per year: | +60.11% (0.5309) |
| Change price per 3 year: | +82.01% (0.467) |
| Change price per 5 year: | -90.81% (9.25) |
| Change price per year to date: | 0% (0.85) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| UBS Group AG | 33522 | 0.38 |
| Rhumbline Advisers | 6678 | 0.08 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Haohan Xu | Chairman of the Board & CEO | N/A | 1995 (30 years) |
| Ms. Xiaoyu Li | Director & CFO | N/A | 1989 (36 years) |
| Mr. Weidong Dai | China President | N/A | 1961 (64 years) |
| Dr. Sunil Pandit | U.S. Chief Executive Officer | N/A | |
| Mr. Yidong Hu | Chief Strategy Officer | N/A |
Address: United States, New York, 650 5th Ave - open in Google maps, open in Yandex maps
Website: https://fresh2.co
Website: https://fresh2.co
